Gossamer Bio, Inc. (FRA:4GB)
Germany flag Germany · Delayed Price · Currency is EUR
1.740
-0.088 (-4.81%)
Feb 20, 2026, 4:00 PM EST

Gossamer Bio Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
418198186191751573
Market Cap Growth
67.29%6.40%-2.77%-74.52%31.08%-32.53%
Enterprise Value
4387984110591269
Last Close Price
1.740.780.781.499.357.75
PS Ratio
11.151.79----
PB Ratio
-5.966.953.2816.947.032.19
P/TBV Ratio
-6.953.2816.947.032.19
EV/Sales Ratio
11.710.71----
Debt / Equity Ratio
-2.466.883.3918.691.530.57
Net Debt / Equity Ratio
-0.28-3.11-1.34-2.48-1.15-1.03
Net Debt / EBITDA Ratio
-0.151.550.490.140.651.57
Net Debt / FCF Ratio
-0.1426.420.530.160.741.85
Asset Turnover
0.160.37----
Quick Ratio
3.066.665.755.198.1613.27
Current Ratio
3.286.895.945.328.3213.51
Return on Equity (ROE)
--122.54%-480.50%-343.53%-105.85%-72.30%
Return on Assets (ROA)
-34.25%-11.94%-37.17%-44.34%-30.58%-27.25%
Return on Capital Employed (ROCE)
-104.50%-22.20%-66.70%-97.90%-71.10%-42.10%
Earnings Yield
-31.81%-27.58%-87.42%-112.15%-27.39%-34.71%
FCF Yield
-32.28%-1.69%-77.38%-91.64%-22.29%-25.37%
Buyback Yield / Dilution
-0.46%-48.23%-80.46%-13.00%-9.24%-25.16%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.